British Society for Haematology. Listening. Learning. Leading British Society for Haematology. Listening. Learning. Leading
020 7713 0990
Annual Scientific Meeting
Login
Sign Up
Apply for Membership Website Registration
020 7713 0990
  • About Us
    • Contact Us
    • Board of Trustees
    • Committees
      • BSH Enterprises
      • Communications
      • Education
      • External Affairs
      • Finance
      • Governance
      • Guidelines
      • Programme
      • Research and Grants
    • Special Interest Groups
      • Global Haematology SIG
      • Laboratory SIG
      • Lymphoma SIG
      • Myelodysplastic Syndrome SIG
      • Obstetric Haematology SIG
      • Paediatric SIG
      • Supportive Care SIG
      • Teenage and Young Adult SIG
    • Early Careers Forum
    • Awards and Prizes
    • Volunteer with us
      • External Opportunities
    • Articles of Association, Regulation and Signed Accounts
    • Work for us
    • Strategy 2024-26: Improving lives in the haematology community
    • Website FAQs
  • Education
    • Conference and events
      • Events
      • Annual Scientific Meeting
      • Promote your haematology event
      • Event Terms and Conditions
      • Crucible Prize
      • Event FAQs
    • Lectures and Videos
      • The Limbic coverage of Annual Scientific Meeting 2024
      • Annual Scientific Meeting 2023
      • 2023 BSH ASM Birmingham - Selected Sessions
      • Previous Pitfall Lectures and Videos
      • Haematology Essentials
      • Demonstration Videos
      • Global SIG Virtual CPD talks
    • Education resources
      • Case Reports
      • Multiple Choice Questions
      • Essay Questions
      • Extended Matching Questions
      • ST3 Laboratory Induction
      • External Resources & Other Organisations
      • Haematology images
    • Students
    • Submit content
  • Grants
    • Annual Scientific Meeting Scholarships
    • ASH-BSH Abstract Achievement Award
    • Conference Awards
    • Genomics Grant
    • Global Haematology Fellowship
    • Global Haematology Scholarship
    • Innovation Research Grants
    • Meeting Support
    • Student Elective Scholarships
    • Grants - our impact
    • Grants FAQs
  • Guidelines
    • About our Guidelines
    • Proposing and writing a new BSH Guideline
    • Sounding Board
  • Membership
    • Membership Signup
    • Meet our members
    • Member updates
    • Your career and wellbeing
    • British Journal of Haematology
    • BSH-EHA Joint Membership
    • Membership FAQs
    • Event Proposal
  • News
  • Advocacy
    • The Haematology Workforce
  • Home
  • Site Map

Site Map

  • Home
    • About Us
      • Contact Us
      • Board of Trustees
      • Committees
        • Communications
        • BSH Enterprises
        • Education
        • External Affairs
        • Finance
        • Guidelines
          • Transfusion Task Force
          • General Haematology Task Force
          • Haemato–Oncology Task Force
          • Haemostasis and Thrombosis Task Force
        • Programme
        • Research and Grants
        • Governance
      • Special Interest Groups
        • Global Haematology SIG
          • Zambia Sickle Cell Disease Task Force
          • BSH Global Speakers
          • Health Volunteers Overseas (HVO) Scheme
        • Laboratory SIG
          • Digital Haematology Task Force
          • Laboratory SIG Genomics
        • Lymphoma SIG
        • Myelodysplastic Syndrome SIG
        • Obstetric Haematology SIG
        • Paediatric SIG
          • Paediatric Haematology Trainee Network (PHTN)
            • PHTN Teaching Sessions
        • Supportive Care SIG
        • Teenage and Young Adult SIG
      • Early Careers Forum
      • Awards and Prizes
      • Volunteer with us
        • External Opportunities
      • Articles of Association, Regulation and Signed Accounts
      • Website FAQs
      • Work for us
      • News
        • June 2025 Message from BSH President - Dr Sue Pavord
        • Epigenetic enzyme role in aggressive AML
        • Fusion protein targeted for AML treatment
        • Home care that may protect lymphoma patients from heart failure
        • BSH Statement on the 10 Year Health Plan
        • Chemotherapy impact on blood genome revealed
        • Key MDS mutation uncovered
        • Soil microbe could lead to new lymphoma treatment
        • Breakthrough in artificial blood production
        • New hope for CAR-T for T-cell ALL
        • Plan to improve lung cancer detection among Hodgkin’s survivors
        • BSH Crucible Prize: Interview with 2025 winner, Georgina Santiapillai
        • BSH statement on Serious Hazards of Transfusion (SHOT) Transfusion Safety Standards
        • Backing for stem cell transplants with mismatched donors
        • Complement inhibitors may tackle sickle cell complications
        • Nuclear power stations cleared of child cancer link
        • July 2025 Message from BSH President - Dr Sue Pavord
        • August 2025 Message from BSH President - Dr Sue Pavord
        • President’s Update – Dr Sue Pavord (September 2025)
        • President’s Update – Dr Sue Pavord (November 2025)
        • President’s Update – Dr Sue Pavord (December 2025)
        • SIG Highlights 2025
        • Blood Thinners and Pregnancy: Information for People with Mechanical Heart Valves
        • President’s Update – Dr Sue Pavord (January 2026)
        • Progressing Liaison Haematology
        • President’s Update – Dr Sue Pavord (February 2026)
        • 2026 Board of Trustees Election results are in!
        • President’s Update – Dr Sue Pavord (March 2026)
        • Final message from Outgoing President Dr Sue Pavord
        • BSH Farewell to Outgoing President Dr Sue Pavord
      • Apply for a Committee or SIG vacancy
      • Membership Terms and Conditions
      • Terms & Conditions
      • Strategy 2024-26: Improving lives in the haematology community
    • Education
      • Conference and events
        • Events
          • Haematology in Obstetrics course 2025
          • Haematological Malignancy Diagnostic Service (HMDS) Course (3)
          • 2025 ST3 Induction Day
          • ESH 7th International Conference: Acute Myeloid Leukemia “Molecular and Translational”: Advances in Biology and Treatment - #ESHAML2025
          • ESH 8th Translational Research Conference: Lymphoid Malignancies - #ESHLYMPHOID2025
          • ESH-iCMLf 27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy - #ESHCML2025
          • ESH 3rd How I Manage: CAR-T Therapies and Bispecific Antibodies for my patients - #ESHCART2025
          • BSBMTCT Scientific Showcase: Advanced Cellular Therapy (4)
          • What's New In Haematological Malignancies
          • UK and Ireland MPN Educational Day...for MPN and CML Nurses, Pharmacists & AHPs
          • Global SIG Virtual CPD Talks Acute Lymphoblastic Leukaemia
          • BSH Paediatric SIG/PHTN Teaching Session July 2025
          • Haematology Highlights for the UK - Post Summer Congresses
          • The HMDS Annual Haematopathology Update Day (1)
          • Yorkshire Myeloid Update Day
          • 6th South West Acute Leukaemia Forum
          • EXPERT-PE 2025 conference
          • FRCPATH -1 Haematology exam course
          • St Mary’s One-Day Intensive Morphology Update for Biomedical Scientists and 1st and 2nd Year Specialist trainees
          • St Mary's One-Day Course in Laboratory Aspects of Haemoglobinopathy Diagnosis
          • Integrated Diagnostics - Haematology and Histopathology
          • St Mary's Two-Day Course in Advanced Haematology Morphology
          • Advancing Gender Equity in Bleeding Disorders
          • BSH Obstetric Haematology SIG Annual meeting
          • 2025 BSH IMT day Leicester
          • Global SIG Virtual CPD Talks 'Management of Haemophilia'
          • BSH Paediatric SIG/PHTN Teaching Session September 2025
          • BSH Lymphoma SIG MDT dilemmas
          • 2026 BSH Paediatric Special Interest Group Meeting
          • UK MDS Education Day
          • BSH Haematology Taster Day 2025
          • Return to work day January 2026
          • VTE together
          • South West Lymphoma Group (6)
          • 10th International Transplant and Cellular Therapy Course
          • Graft versus Host Disease (GvHD) Preceptorship 2025
          • 8th South West Stem Cell Transplant Day
          • CAR-T Therapy for Autoimmune Diseases
          • Current Thinking in Haematological Malignancies (12)
          • Annual Sickle Cell & Thalassaemia Conference
          • KEY ADVANCES IN CLL
          • Improving Data Quality: The National Non-Hodgkin Lymphoma Audit Quality Improvement Focus
          • FEBS Workshop on the Molecular and Cellular Pathways of Aging in Haematopoiesis
          • National ALL Update Day (2)
          • British Lymphoma Pathology Group Autumn 2025 Meeting
          • Global SIG Virtual CPD Talks on the principle of bone marrow aspirate interpretation
          • An Introduction To Haematology
          • Current Thinking in Haematological Malignancies (13)
          • South West Haemostasis and Thrombosis Meeting (6)
          • National ALL Update Day (3)
          • UK North Myeloma Forum (3)
          • Myeloproliferative Neoplasms Advances Day 2025
          • UK Lymphoma Research Group (1)
          • CAR-T Study Day for Nursing & Allied Healthcare Professionals
          • Fourth Burgos ITP Meeting
          • Haematological Malignancy Diagnostic Service (HMDS) Course (4)
          • Haematology: Presentation, Prevention and Possibilities
          • BCS/BCOS/UCLH Cancer Academy Cardio-Oncology Course 2025
          • BSH Paediatric SIG/PHTN Teaching Session November 2025
          • How Tests Help Patients
          • Haematology in Obstetrics course 2026
          • Haematology Nurse Study Day
          • FRCPATH 1 EXAM REVISION COURSE
          • New Consultants Day
          • SOHO UK
          • UCLH: Challenges in MPN 2026
          • Back to events General Haematology in Practice Study Day
          • Caring for the Critically Ill Haematology Patient - UCLH Study Day
          • Scotland Myeloid Update Day
          • Post ASH Highlights for Scotland
          • Post ASH Significant Highlights (5)
          • BSH Paediatric SIG/PHTN Teaching Session March 2026
          • Recent Advances and Reflections in Chronic Myeloid Leukaemia
          • Recent Advances in Haematology 2026, including ASH Highlights 2025
          • 2nd North of England Autoimmune CAR T Day
          • One-Day Intensive Morphology Update for Biomedical Scientists and 1st and 2nd Year Specialist Trainees
          • Laboratory Aspects of Haemoglobinopathy Diagnosis (3)
          • Integrated Diagnostics - Haematology and Histopathology (1)
          • Two-Day Course in Advanced Haematology Morphology
          • Essentials in Haematology
          • Crossroads in Haematology: Diagnostic and Management Pitfalls Across Specialties
          • ESH 4th Translational Research Conference: Chronic Lymphocytic Leukaemia - #ESHCLL2026
          • ESH 11th Translational Research Conference: Myeloproliferative Neoplasms - #ESHMPN2026
          • ESH 8th Translational Research Conference: Multiple Myeloma - #ESHMM2026
          • ESH 5th How to Diagnose and Treat ACUTE LEUKAEMIAS - #ESHAL2026
          • The Cardiac TTR-Amyloid Imaging Study Day
          • 3rd GVHD Academy
          • UKMS Spring Day (1)
          • UK CLL Forum Annual Scientific Day (6)
          • UK North Myeloma Forum (4)
          • What's New in Haematological Malignancies (3)
          • South West Myeloma Group (8)
          • Scientist career development - what comes next
          • Haematology for IMTs
          • 2026 ST3 Induction Day
          • UCLH Advanced Haematology and Stem Cell Transplant Nursing: A Masterclass Series
          • TYA Webinar on Fertility
          • BSH Paediatric SIG/PHTN Teaching Session May 2026
          • Return to Work Day June 2026
          • Royal Marsden Imaging Perspectives: Imaging in Haematological Malignancies; Myeloma.  Lymphoma.  Leukaemia Monday
          • CAR-T Preceptorship
          • Anticoagulation Study Day 2026
          • 5th International Conference on Nursing Education and Research
          • Post-ASH Educational Meeting
          • How to Manage: Paediatric Sickle Cell
          • CAR-T Study Day
          • Crescent Cell, Sickle Moon
          • Summer Congress Insights: From Evidence to Practice – Insight Meetings
          • BSH Paediatric SIG/PHTN Teaching Session July 2026
        • Events
        • Annual Scientific Meeting
        • Promote your haematology event
        • Event Terms and Conditions
        • Crucible Prize
        • Event FAQs
        • BSH 2024 Lymphoma Special Interest Group - MDT Dilemmas
        • 2023 BSH Lymphoma SIG Online Meeting: MDT Dilemmas
        • 2023 BSH ASM: Lifestyle Medicine Recording
        • 2023 BSH ASM: New Horizons Recording
        • Equitable partnerships and sharing learning - test
        • Student Communication Prize
      • Lectures and Videos
        • The Limbic covereage of Annual Scientific Meeting 2023
        • 2023 BSH ASM Birmingham - Selected Sessions
        • Demonstration Videos
        • Patient Perspective: The journey of Pain in Sickle Cell Disease
        • Global SIG Virtual CPD talks
        • BSH Lymphoma SIG MDT dilemmas
        • The National Non-Hodgkin Lymphoma Audit Quality Improvement Focus webinar
        • National Pathology Week Webinars 2025
      • Haematology images
        • Bone Marrow Transplantation
          • Haemolytic-uraemic syndrome after stem cell transplantation
        • General Haematology
          • Atypical lymphocyte in primary HIV infection
          • Trephine biopsy in malignant melanoma
          • Bone marrow aspirate in malignant melanoma
          • Platelet aggregates, blood film
          • Oxalosis, trephine biopsy section
          • Intra-pelvic haemorrhage following trephine biopsy: CT scan of pelvis
          • Paroxysmal nocturnal haemoglobinuria associated with haemophagocytic syndrome
          • Gelatinous transformation
          • Jordans' anomaly
          • Cobra like macrophage in visceral leishmaniasis
          • Bacilli in blood film
          • Bacilli in blood film in pseudomonas septicemia
          • Multiple mitochondria in normal and tumour cells
          • Congenital Pelger–Huët anomaly
          • Oral haematoma
          • Histoplasma in peripheral blood neutrophil
          • Burkitt-like cytology in biphenotypic acute leukaemia
          • Burkitt-like cytology in biphenotypic acute leukaemia (1)
          • Extreme neutrophil vacuolisation in sepsis
          • Striking monocyte vacuolisation in sepsis
          • Toxic granulation and striking vacuolisation of neutrophils in sepsis
          • Intramonocytic malarial pigment
          • Histoplasmosis in bone marrow
          • Mycobacterium avium intracellulare infection in a patient with AIDS
          • Mycobacterium avium intracellulare (MAI) on routine H&E stain of a bone marrow section from a patient with AIDS
          • Diagnosis of systemic lupus erythematosus by bone marrow cytology
          • LE cells in incubated bone marrow
          • SLE diagnosed from bone marrow
          • Metastatic malignant melanoma in bone marrow, MGG stain
          • Metastatic malignant melanoma in bone marrow trephine biopsy section, immunohistochemistry, APAAP technique, with hmb45
          • Toxic Granuation and Döhle bodies in a patient with severe bacterial infection
          • Bone marrow sarcoidosis in a patient with diffuse large B-cell lymphoma
          • Visceral leishmaniasis (2)
          • Visceral leishmaniasis (3)
          • Letterer-Siwe disease (1)
          • Letterer-Siwe disease (2)
          • Letterer-Siwe disease (3)
          • Letterer-Siwe disease (4)
          • Alveolar rhabdomyosarcoma infiltrating the bone marrow
          • Bone marrow aspirate in Niemann-Pick disease
          • Leishmaniasis
          • Haemophagocytosis in probable typhoid fever (1)
          • Haemophagocytosis in probable typhoid fever (2)
          • Haemophagocytosis in probable typhoid fever (3)
          • Haemophagocytosis in probable typhoid fever
          • Probable granuloma in typhoid fever (1)
          • Probable granuloma in typhoid fever (2)
          • Döhle bodies and toxic granulation
          • Endothelial cells, low power
          • Endothelial cells, high power
          • Binucleated lymphocytes
          • Cytoplasmic fragments mistaken for malaria parasites (1)
          • Cytoplasmic fragments mistaken for malaria parasites (2)
          • Cytoplasmic fragments mistaken for malaria parasites (3)
          • Haemosiderin in a plasma cell, May-Grünwald-Giemsa stain
          • Tuberculous granulomas in a trephine biopsy section, low power
          • Tuberculous granulomas in a trephine biopsy section, low power (ii)
          • Tuberculous granulomas in a trephine biopsy section, high power
          • Toxic granulation and left shift induced by G-CSF
          • Nuclear dysplasia and Döhle body formation induced by G-CSF
          • Neutrophil vacuolation induced by G-CSF
          • Multiple Döhle bodies and nuclear dysplasia induced by G-CSF
          • Döhle body and vacuolation induced by G-CSF
          • Left shift, toxic granulation, Döhle bodies and nuclear dysplasia induced by G-CSF
          • Dysplastic neutrophil with ring-shaped nucleus following G-CSF therapy
          • Alder-Reilly anomaly in a neutrophil
          • Alder-Reilly anomaly in two neutrophils
          • Gasser cell (lymphocyte with heavy granules)
          • Monocyte with heavy granules and vacuoles as the result of a mucopolysaccharidosis
          • Neutrophil showing Alder-Reilly anomaly
          • Lymphocyte in mucopolysaccharidosis
          • Monocyte in mucopolysaccharidosis
          • Carcinoma cells infiltrating bone marrow with reactive fibrosis
          • Carcinoma cells infiltrating bone marrow (2) with reactive fibrosis
          • Carcinoma cells in an imprint from a trephine biopsy section, low power
          • Carcinoma cells in an imprint from a trephine biopsy section, high power
          • PAS-block positivity suspected from a Romonowsky-stained film
          • Buffy coat film showing a clump of carcinoma cells
          • Sea-blue histiocyte
          • Sea-blue histiocytes
          • Melanonychia striata secondary to hydroxycarbamide
          • Chemotherapy-induced dysplasia
          • Leishman-Donovan bodies in the bone marrow
          • Leishmaniasis (1)
          • Cohesive epithelioid macrophages in a bone marrow aspirate indicating the presence of granulomas (low power)
          • Cohesive epithelioid macrophages in a bone marrow aspirate indicating the presence of granulomas (high power)
          • Histology of bone marrow granuloma, H& E, low power
          • Histology of bone marrow granuloma, H& E, high power
          • Erythroid island
          • A Mott cell
          • Haemophagocytosis in the bone marrow aspirate of a young woman with coeliac disease
          • Gaucher disease discovered during pregnancy
          • Normal bone marrow film, Jenner-Giemsa with phosphate buffer at pH 6.6
          • Infection-related haemophagocytic lymphohistiocytosis (HLH) in a HIV stage 4 patient with Mycobacterium tuberculosis infection
          • Neuroblastoma with neuropil
          • Emperipolesis in a patient with RAEB-2
          • Dural biopsy in extranodal Rosai-Dorfman disease, which radiologically and histologically mimicked meningioma (H& E)
          • Dural biopsy in extranodal Rosai-Dorfman disease, which radiologically and histologically mimicked meningioma (immunohistochemistry for S-100)
          • Fragmentation haemolysis secondary to sepsis in a three-month-old female infant
          • Plasmacytoid lymphocyte (Tϋrk cell)
          • Congenital hip dislocation in Fanconi anaemia, X-ray
          • Howell-Jolly body-like neutrophil inclusion (1)
          • Howell-Jolly body-like neutrophil inclusion (2)
          • Monocytes ‒ yes, but monotony ‒ never!
          • Haemophagocytic lymphohistiocytosis
          • Reactive myelofibrosis in metastatic tumour of unknown origin
          • Reactive myelofibrosis (reticulin stain) in a metastatic tumour of unknown origin
          • Plasmodium falciparum gametocyte (i)
          • Plasmodium falciparum gametocyte (ii)
          • Reactive haemophagocytosis in a bone marrow aspirate
          • The stages of mitosis
          • Haemoglobin H disease
          • Bone marrow metastatic involvement by penile squamous cell carcinoma
          • Crystal-storing histiocytosis associated with plasma cell myeloma
          • Neutrophils changed appearance with a new heart
          • LD bodies with marrow plasmacytosis
          • Tadpole in the marrow
          • Large granular lymphocyte, blood film
          • Perls' stain showing iron in macrophages
          • Erythroid island with central macrophage
          • Reactive lymphocytes in infection by Brucella spp (Brucellosis, also called undulant fever, or Malta fever)
          • Disseminated metastatic prostatic carcinoma in a young male (1)
          • Histoplasma in peripheral blood and bone marrow
          • Howell-Jolly body-like inclusions in reactive myelocytes and metamyelocytes
          • Non-immune haemolytic anaemia in a severe burns patient
          • Mycobacterium avium intracellulare on bone marrow trephine
          • Cryptococcus neoformans: Cerebrospinal fluid (CSF) cytospin and bone marrow trephine
          • Prostatic adenocarcinoma metastasis in bone marrow (H&E stain)
          • Haemophagocytic lymphohistocytosis successfully treated with Anakinra therapy
        • Immunobiology
        • Lymphoid Malignancy
          • Simultaneous diagnosis of precursor B-cell acute lymphoblastic leukaemia and chronic lymphocytic leukaemia, high power
          • Neurolymphomatosis
          • Anaplastic large cell lymphoma lymphoma
          • Multiple myeloma 2, giant cell
          • Syncytial neoplastic cells in paediatric Hodgkin lymphoma
          • Hodgkin lymphoma in the bone marrow, trephine biopsy section, H& E, low power
          • Hodgkin lymphoma in the bone marrow, trephine biopsy section, immunohistochemistry for CD30, low power
          • Hodgkin lymphoma in the bone marrow, trephine biopsy section, H& E, high power, 1
          • Hodgkin lymphoma in the bone marrow, trephine biopsy section, H& E, high power, 2
          • Classical Reed-Sternberg cell in film of fine needle aspirate (Jenner-Giemsa stain)
          • Lymph node biopsy in Hodgkin lymphoma
          • Immunohistochemistry in Hodgkin's disease (Hodgkin lymphoma)
          • Blood film of mantle cell lymphoma in evolution
          • Paratrabecular infiltration in follicular lymphoma
          • Diffuse large B-cell lymphoma
          • Finger necrosis in cold agglutinin disease
          • Type 1 cryoglobulinaemia in a patient with low grade non-Hodgkin lymphoma
          • Rouleaux formation in lymphoplasmacytic lymphoma
          • Splenic marginal zone lymphoma with peripheral blood lymphocyte clusters
          • Diffuse large B-cell lymphoma in leukaemic phase
          • Comparison of Ki67 positivity in mantle cell lymphoma (left) and in blastoid transformation (right)
          • FDG-PET scan in cutaneous blastoid mantle cell lymphoma showing intense activity in a subcutaneous nodule
          • Cold agglutinin in non-Hodgkin lymphoma
          • Follicular lymphoma in leukaemic phase
          • Marginal zone lymphoma of bone: MRI appearance
          • Marginal zone lymphoma of bone: histology
          • Marginal zone lymphoma of bone: immunohistochemistry
          • PET/CT showing neurolymphomatosis as the presenting feature in a relapsed diffuse large B-cell lymphoma
          • Bone marrow aspirate in primary diffuse large B-cell lymphoma of bone marrow (i)
          • Bone marrow aspirate in primary bone marrow diffuse large B-cell lymphoma (ii)
          • Hairy cell leukaemia
          • Anaplastic large cell lymphoma, ALK-positive, in pleural fluid
          • Ziehl-Neelsen (ZN) stain demonstrating acid-fast bacilli, identified as M. chelonae, which were the cause of vascular-catheter-related bacteraemia
          • Anaplastic large T-cell lymphoma
          • Primary cutaneous T-cell non-Hodgkin lymphoma on the shin completely healed following radiotherapy
          • Skin infiltration in patient with adult T-cell leukaemia/lymphoma
          • Primary cutaneous ALK-negative anaplastic large T-cell lymphoma
          • Blood film in adult T-cell leukaemia/lymphoma
          • Immunohistochemistry in subcutaneous panniculitis-like T-cell lymphoma
          • Sézary cells
          • Anaplastic large cell lymphoma overspill into peripheral blood
          • Leukaemic phase of extranodal NK/T cell lymphoma of nasal type, peripheral blood film
          • Anaplastic large cell lymphoma
          • Peripheral blood in T-prolymphocytic leukaemia
          • Hyperpigmentation and nodularity of skin in POEMS syndrome
          • Circulating myeloma cell in a patient with refractory multiple myeloma
          • Extramedullary myeloma
          • Multiple myeloma cells in cerebrospinal fluid
          • Extramedullary plasmacytoma of lung, haematoxylin and eosin
          • Flaming plasma cell in IgA myeloma
          • Pathological fracture of the proximal third of the shaft of the left humerus in multiple myeloma
          • Cryoglobulinaemia
          • CT scan of the pelvis in amyloidosis
          • Plasmacytoma of the orbit in multiple myeloma, MRI scan (2)
          • Plasmacytoma of orbit, histology following orbital biopsy: left, hematoxylin and eosin; right, immunohistochemistry for CD38
          • Histology and immunohistochemistry of unusual skin lesions in multiple myeloma
          • Bone marrow in multiple myeloma (1)
          • Bone marrow in multiple myeloma (4): unusual cytoplasmic inclusions in myeloma cells
          • Bone marrow in multiple myeloma (5): unusual cytoplasmic inclusions in myeloma cells
          • Myeloma cells with crystals (i)
          • Myeloma cells with crystals (ii)
          • Myeloma cells with crystals (iii)
          • Auer-rod like crystals in macrophages in myeloma (i)
          • Auer rod-like crystals in macrophages in multiple myeloma (ii)
          • Extramedullary plasmacytoma of the sphenoid sinus: T2 weighted MRI image
          • Phagocytosis by myeloma cells
          • Circulating plasma cells and rouleaux in plasma cell leukaemia
          • Plasmablast in plasma cell leukaemia
          • Auer-rod like inclusions in multiple myeloma
          • Myeloma cells including a trinucleated cell containing Auer-rod-like inclusions
          • Tissue biopsy section, multiple myeloma, haematoxylin and eosin
          • Giant myeloma cells
          • Giant binucleate myeloma cell
          • Giant trinucleate myeloma cell
          • Giant quadranucleate myeloma cell
          • Neoplastic pleural effusion in refractory multiple myeloma
          • Intracranial plasmacytoma causing bilateral sixth nerve palsy (1)
          • Intracranial plasmacytoma causing bilateral sixth nerve palsy (2)
          • Multinucleated tumour cell in multiple myeloma
          • Multinucleated cell in multiple myeloma
          • Multinucleated plasma cell in multiple myeloma
          • Giant multinucleated tumour cells in multiple myeloma
          • A giant multinucleated tumour cell in multiple myeloma
          • Rouleaux formation and plasma cell - peripheral blood film of a patient with multiple myeloma
          • Plasma cells in multiple myeloma - peripheral blood film
          • Multiple myeloma 5, Dutcher body
          • Multiple myeloma (1)
          • Multiple myeloma (2)
          • Multiple myeloma (3)
          • Multiple myeloma (4)
          • Multiple myeloma (5)
          • Multiple Myeloma 1, Dutcher bodies
          • Blood film in chronic lymphocytic leukaemia, mixed cell type
          • CT scan showing a macronodular pattern of infiltration in chronic lymphocytic leukaemia
          • CLL and metastatic tumour
          • Aggressive NK cell leukaemia/lymphoma
          • Aggressive NK cell lymphoma
          • Flow cytometry in NK-lineage large granular lymphocytic leukaemia
          • Trephine biopsy in Hodgkin's disease
          • Bone marrow aspirate showing a Reed-Sternberg cell
          • Foamy macrophages in ALL
          • A typical basket-shaped smear cell in acute lymphoblastic leukaemia
          • A small blast cell in the peripheral blood
          • Symptomatic osteonecrosis of the knee in a patient with Hodgkin lymphoma
          • Gross disfigurement secondary to extensive diffuse large B-cell lymphoma of the scalp
          • Hyperhaploid multiple myeloma: very rare high-risk genetic subtype
          • Intracardiac lymphoma on MRI imaging.
          • Russell bodies in bone marrow of patient with lymphoplasmacytic lymphoma (1)
          • Russell bodies in bone marrow of patient with lymphoplasmacytic lymphoma (2)
          • Bi-nuclear lymphocyte
          • AITL-RDD
          • T-ALL relapsing as AML: the same but different
          • Predominance of plasma cells
          • CAR-T cells found in CSF
        • Myeloid Malignancy
          • Transformation of essential thrombocythemia to pure erythroid leukaemia
          • Chronic myelomonocytic leukaemia
          • Imatinib-induced myelodysplasia: clues in a peripheral blood film
          • Leukaemia cutis
          • Chronic myeloid leukaemia in accelerated phase
          • Chronic myeloid leukaemia in chronic phase
          • Hypopyon in blast crisis of chronic myelogenous leukaemia
          • CML - Hypolobated small megakaryocyte and a pseudo-Gaucher cell
          • Promyelocyte with a loose bundle of Auer rods acute promyelocytic leukaemia
          • The retina in acute myeloid leukaemia
          • Cytoplasmic RNP and basic protein content of blasts in AML
          • ATRA-induced scrotal ulcers
          • Fluorescence in situ hybridisation with ABL and RUNX1 probes (red) and ETV6 and BCR probes (green)
          • Peripheral blood film in AML with t(9;11)(p22;q23)
          • Blastic plasmacytoid dendritic cell neoplasm, clinical photograph
          • Blood film in acute megakaryoblastic leukaemia
          • Blood film in acute megakaryoblastic leukaemia (1)
          • Acute basophilic leukaemia, bone marrow aspirate
          • Clinical features of haematodermic CD4+CD56+ neoplasm (blastic plasmacytoid dendritic cell neoplasm)
          • Haemophagocytosis
          • Acute megakaryoblastic leukaemia, peripheral blood
          • Acute myeloid leukaemia, blood film
          • AML with Pseudo-Chédiak-Higashi granules
          • BM aspirate in acute promyelocytic leukaemia
          • Auer rods
          • PAS-positivity in acute erythroid leukaemia
          • Acute leukaemia with histiocytic differentiation (1)
          • Acute myeloid leukaemia with histiocytic differentiation (2)
          • Acute myeloid leukaemia with histiocytic differentiation (3)
          • Acute myeloid leukaemia with histocytic differentiation (4)
          • Acute myeloid leukaemia in a patient with b thalassaemia major, post-splenectomy (1)
          • Acute myeloid leukaemia in a patient with b thalassaemia major, post-splenectomy
          • Auer rods in a neutrophil following ATRA treatment of acute promyelocytic leukaemia (i)
          • Auer rod in a neutrophil in a patient with acute promyelocytic leukaemia treated with ATRA (ii)
          • Dysplastic neutrophil during ATRA treatment of acute promyelocytic leukaemia (i)
          • Dysplastic neutrophil during ATRA treatment of acute promyelocytic leukaemia (ii)
          • Unusually large granules in M1 AML (i)
          • Unusually large granules in M1 AML (ii)
          • Unusually large granules in M1 AML (iii)
          • Unusually large granules in M1 AML (iv)
          • Unusually large granules in M1 AML (v)
          • Unusually large granules in M1 AML (vi)
          • Unusually large granules in M1 AML (vii)
          • Unusually large granules in M1 AML (viii)
          • Peripheral blood film in acute monoblastic leukaemia (Jenner-Giemsa stain)
          • Bone marrow aspirate film in acute monoblastic leukaemia (Jenner-Giemsa stain)
          • Non-specific esterase (NSE) in acute monoblastic leukaemia (substrate: alpha naphthyl acetate esterase)
          • Extracellular Auer rods: Can this be another clue to a diagnosis of acute promyelocytic leukaemia?
          • Acute monocytic leukaemia with leukaemic cells resembling histiocytes (i)
          • Acute monocytic leukaemia with leukaemic cells resembling histiocytes (ii)
          • Acute monocytic leukaemia with leukaemic cells resembling histiocytes (iii); note long cytoplasmic tails of some cells
          • Acute monocytic leukaemia with leukaemic cells resembling histiocytes (iv); note that several cells have long cytoplasmic tails
          • Mitotic figure in a leukaemic cell in a patient with acute monocytic leukaemia with leukaemic cells resembling histiocytes (v)
          • Cytological/cytochemical diagnosis of the variant form of acute promyelocytic leukaemia
          • Morphological diagnosis of variant form of acute promyelocytic leukaemia, MGG (i)
          • Morphological diagnosis of variant form of acute promyelocytic leukaemia, MGG (ii)
          • Sudan black B stain in the variant form of acute promyelocytic leukaemia, SBB (i)
          • Sudan black B stain in the variant form of acute promyelocytic leukaemia, SBB (ii)
          • Sweet syndrome
          • Blood film of a four-day-old baby with Down syndrome and transient abnormal myelopoiesis showing blast cells
          • Blood film of a four-day-old baby with Down syndrome and transient abnormal myelopoiesis showing an immature cell of basophil lineage
          • Blood film of a four-day-old baby with Down syndrome and transient abnormal myelopoiesis showing a nucleated red blood cell and a blast cell
          • Dysplastic maturation during ATRA treatment of acute promyelocytic leukaemia
          • Acute basophilic leukaemia, bone marrow, toluidine blue stain
          • Acquired haemoglobin H disease
          • Circulating dysplastic megakaryocyte in Down syndrome
          • Hypolobulated megakaryocyte in 5q- syndrome
          • Myelodysplastic syndrome, nuclear abnormalities
          • Increased iron stores in refractory anaemia with excess of blasts
          • Hypolobated megakaryocytes in refractory anaemia with excess of blasts
          • Increased and dysplastic megakaryocytes in refractory anaemia with excess of blasts
          • Dysplastic megakaryocytes, blast cells and increased proerythroblasts in RAEB
          • A hypolobated megakaryocyte and immature cells, probably proerythroblasts, in a patient with RAEB
          • Disorganised marrow in RAEB with increased immature cells, probably blast cells as well as proerythroblasts
          • Myeloid neoplasm with FIP1L1-PDGFRA
          • Intravascular haematopoiesis
          • CT of chest showing extramedullary haemopoiesis
          • Juvenile myelomonocytic leukaemia in beta thalassaemia major, low power of peripheral blood film
          • Juvenile myelomonocytic leukaemia in beta thalassaemia major, high power view of blood film (1)
          • Juvenile myelomonocytic leukaemia in beta thalassaemia major, high power view of blood film (2)
          • Juvenile myelomonocytic leukaemia in beta thalassaemia major, high power view of blood film (3)
          • Splenic histology in a patient with advanced primary myelofibrosis
          • Essential thrombocythaemia - giant megakaryocyte
          • Systemic mastocytosis, bone marrow aspirate
          • Emperipolesis
          • Emperipolesis (1)
          • PB, primary myelofibrosis
          • Bone marrow trephine biopsy in primary myelofibrosis, low power
          • Bone marrow biopsy - Parrafin embedded section - Masson trichrome stain - PRIMARY MYELOFIBROSIS showing collagen fibrosis & osteomyelosclerosis
          • Neonatal Langerhans cell histiocytosis(LCH) showing reactive haemophagocytosis in the bone marrow aspirate
          • MYC overexpressing acute myeloid leukaemia with botryoid white cell nuclei as well as unusual cytoplasmic inclusions
          • Blastic plasmacytoid dendritic cell leukaemia
          • Acute promyelocytic leukaemia (APML) like morphology in acute myeloid leukaemis (AML) with myelodysplastic syndrome (MDS) related changes
          • Emperipolesis in megakaryocyte (1)
          • Marrow collagen fibrosis (MT stain) (1)
          • Marrow collagen fibrosis (VG stain) (1)
          • AML with t(8;21)
          • The Rods
          • AML with myelodysplasia-related changes
          • Faggot cells acute pro-myelocytic leukaemia
          • Bone marrow necrosis in acute leukemia
          • Therapy related AML with t(9;11) and KRAS mutation
          • Myeloid blast cells
          • Macrophage phagocytosis of atypical promyelocyte in acute promyelocytic leukemia.
          • AML with MECOM rearrangement
          • AML-pCT (post cytotoxic therapy) with megakaryoblast morphology
          • AML with FLT3-ITD and NPM1 mutation
          • Acute promyelocytic leukaemia (APML) variant presented with pulmonary embolism and pancytopenia
        • Paediatrics
          • Blast cells in a neonate with Down's syndrome
          • Leukaemic hypopyon
          • A micromegakaryocyte in a child with refractory anaemia with excess of blasts-2 (RAEB2)
          • Rhabdomyoblasts in the peripheral blood in rhabdomyosarcoma
          • Hereditary xerocytosis, blood film
          • ABO haemolytic disease of the newborn (HDN)
          • Dystrophic nails in dyskeratosis congenita
          • Osteopetrosis, trephine biopsy section
          • Bilirubin crystals in neonatal hyperbilirubinaemia
        • Platelets and Haemostasis
          • Scurvy
          • Platelet satellitism
          • Normal platelet EM
          • Grey platelet syndrome EM
          • Intraretinal haemorrhage in autoimmune thrombocytopenic purpura
          • Submacular haemorrhage in autoimmune thrombocytopenic purpura
          • Macular retinal atrophy following submacular haemorrhage in autoimmune thrombocytopenic purpura
          • A cord-like fragment of megakaryocyte cytoplasm in the bone marrow of a patient with immune thrombocytopenia
          • Cord-like fragments of megakaryocyte cytoplasm in the bone marrow of a patient with immune thrombocytopenia
          • Haemarthroses
          • Knee showing haemarthrosis
          • Patient with acquired factor VIII deficiency
          • Suspected Bernard-Soulier syndrome, 4
          • Suspected Bernard-Soulier syndrome, 1
          • Suspected Bernard-Soulier syndrome, 2
          • Suspected Bernard-Soulier syndrome, 3
          • Osler-Weber-Rendu disease
          • Haemorrhagic diathesis in a bulimia nervosa patient
          • Haemophilic pseudocyst
        • Red Cell Disorders
          • Pyruvate kinase deficiency, post-splenectomy
          • Erythroid islands: the crèches for the baby erythroids!
          • An erythroid island
          • Stomatocytes
          • Sickle cell anaemia
          • Coexisting sickle cell anaemia and G6PD deficiency
          • Bone marrow fibrosis following bone marrow infarction in sickle cell anaemia
          • Compound heterozygosity for haemoglobin S and haemoglobin C, peripheral blood film
          • Compound heterozygosity for haemoglobin S and haemoglobin C, peripheral blood film, high power
          • Compound heterozygosity for haemoglobin S and haemoglobin C, peripheral blood film, high power (1)
          • Dyserythropoiesis in beta thalassaemia major
          • Erythroid hyperplasia, basophilic stippling and two erythroblasts containing alpha chain inclusions in beta thalassaemia major
          • Two alpha chain inclusions in an erythroblast in a patient with beta thalassaemia major
          • Dyserythropoiesis and an erythroblast containing an alpha chain inclusion in beta thalassaemia major
          • Hyperplastic erythropoiesis and a macrophage containing erythroblasts and cellular debris, a visual representation of ineffective erythropoiesis
          • Iron-laden macrophage in beta thalassaemia major; there is cellular debris and refractile brown haemosiderin within the macrophage
          • An erythroblast in beta thalassaemia major showing dyserythropoiesis (lobulated nucleus)
          • An erythroblast in beta thalassaemia major showing a paranuclear alpha chain inclusion and dyserythropoiesis (lobulated nucleus)
          • Two erythroblasts showing defective haemoglobinisation in beta thalassaemia major
          • Ineffective erythropoiesis in beta thalassaemia major; a macrophage contains phagocytosed erythroblasts and golden-brown haemosiderin
          • Haemoglobin H disease
          • Dyserythropoiesis and Howell-Jolly bodies in defectively haemoglobinised cells. Normal transfused cells are also present
          • Alpha chain inclusion in a circulating erythroblast
          • Alpha chain inclusion surrounded by basophilic stippling in a circulating erythroblast
          • Three erythroblasts containing alpha chain inclusions and small Howell-Jolly bodies
          • Alpha chain inclusions, Howell-Jolly bodies and basophilic stippling
          • Haemoglobin H inclusions
          • Haemoglobin H inclusions (1)
          • Acanthocytosis in abetalipoproteiaemia
          • Dehydrated variant of hereditary stomatocytosis
          • Haemoglobin H disease and G6PD deficiency (1)
          • Haemoglobin H disease and G6PD deficiency (2)
          • Haemoglobin H disease and G6PD deficiency (3)
          • Pyruvate kinase deficiency, post-splenectomy (2)
          • Pyruvate kinase deficiency, post-splenectomy (1)
          • Coexistence of G6PD deficiency and sickle cell anaemia
          • Combined vitamin B12 and folate deficiency
          • Combined B12 and folate deficiency
          • Marked hypochromia and microcytosis in severe iron deficiency anaemia
          • A micronormoblast in the circulation in severe iron deficiency anaemia
          • Elliptocytes (pencil cells) and marked hypochromia and microcytosis in severe iron deficiency anaemia
          • Haemolytic uraemic syndrome, peripheral blood film
          • Plasmodium malariae
          • Malaria in a patient with Southeast Asian ovalocytosis
          • Malaria in a patient with Southeast Asian ovalocytosis (1)
          • Cabot's ring
          • Microangiopathic haemolytic anaemia resulting from a viper bite
          • Lantern cells after kidney transplant
          • Lantern cells after kidney transplant 2
          • Lantern cells after kidney transplant 3
          • Asexual and sexual mature Plasmodium vivax sharing a red cell
          • HbH-like inclusions in congenital sideroblastic anaemia
          • Sickled red blood cells
          • G6PD enzyme deficiency\/AIHA\/Favism
        • Transfusion Medicine
          • Blood grouping, microtitre plate
          • Extravasation of transfused blood
      • Students
      • Submit content
    • Grants
      • Annual Scientific Meeting Scholarships
        • ASM Scholarship Terms and Conditions
      • ASH-BSH Abstract Achievement Award
      • Conference Awards
        • Conference Award Terms and Conditions
      • Genomics Grant
        • Genomics Grant Terms and Conditions
      • Global Haematology Fellowship
        • Global Haematology Fellowship Terms and Conditions
      • Global Haematology Scholarship
        • Global Haematology Scholarship Terms and Conditions
      • Innovation Research Grants
        • Innovation Research Grant Terms and Conditions
      • Meeting Support
        • Meeting Support Grant Terms and Conditions
      • Student Elective Scholarships
        • Student Elective Terms and Conditions
      • Grants - our impact
      • Grants FAQs
    • Guidelines
      • Guidelines
        • Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies
        • Diagnosis of B12 and Folate Deficiency
        • Management of Acute Chest Syndrome in Sickle Cell Disease
        • Modification of Diagnostic Criteria for Essential Thrombocythaemia 
        • Use of Multicolour Flow Cytometry in the Diagnosis of Haematological Neoplasms
        • Diagnosis and management of acquired coagulation inhibitors: a Joint UKHCDO and BCSH Guideline
        • Diagnosis and management of respiratory viral infections in patients with haematological malignancy
        • Haematological Malignancies and ITU 
        • Investigation and Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma
        • Management of AML in Pregnancy
        • Diagnosis and management of the rare coagulation disorders: A UKHCDO Guideline on behalf of BCSH
        • The diagnosis and management of von Willebrand disease: a UKHCDO Guideline approved by BCSH
        • Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition)
        • Guidelines on the investigation and management of venous thrombosis at unusual sites
        • Guideline on the investigation, management and prevention of venous thrombosis in children
        • Guideline on the management of bleeding in patients on antithrombotic agents
        • Oral Anticoagulation with Warfarin - 4th Edition
        • Patient self-testing and self-management of oral anticoagulation with vitamin K antagonists
        • Guidelines on travel-related venous thrombosis
        • Guidelines on use of vena cava filters
        • The administration of blood components
        • Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories
        • The Estimation of Fetomaternal Haemorrhage 
        • Guidelines on transfusion for fetuses, neonates and older children
        • Guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn
        • Guidelines for the use of platelet transfusions
        • Guidelines for validation and qualification, including change control, for hospital transfusion laboratories
        • Investigation and Management of Eosinophilia
        • Diagnosis and Management of Primary Autoimmune Haemolytic Anaemia
        • Management of Drug-Induced Immune and Secondary Autoimmune Haemolytic Anaemia
        • Peri-operative management of anticoagulation and antiplatelet therapy
        • Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects
        • Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion
        • Guidelines for the diagnosis and management of disseminated intravascular coagulation
        • Management of thrombotic and haemostatic issues in paediatric malignancy
        • Spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding
        • Diagnosis and therapy of genetic haemochromatosis (review and 2017 update)
        • Investigation and management of a raised serum ferritin
        • Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease
        • Investigation and management of Transient Leukaemia of Down Syndrome
        • Good practice paper on the diagnosis and investigation of patients with mantle cell lymphoma
        • The use of viscoelastic haemostatic assays in the management of major bleeding
        • Guidelines for the diagnosis and management of primary central nervous system diffuse large B‐cell lymphoma
        • Diagnosis and management of polycythaemia vera
        • Management of specific situations in polycythaemia vera and secondary erythrocytosis
        • Point of Care in General Haematology
        • UK guidelines on the management of iron deficiency in pregnancy
        • Laboratory diagnosis of G6PD deficiency
        • Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B
        • Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis
        • Guideline on the investigation and management of follicular lymphoma
        • Guideline on the diagnosis and management of chronic myeloid leukaemia
        • Guidelines on the use of irradiated blood components
        • Diagnosis and Management of Hereditary Spherocytosis
        • Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL-V)
        • Guideline on Front‐line management of post‐transplantation lymphoproliferative disorder in adult solid organ recipient patients
        • Guidelines for the diagnosis and evaluation of prognosis of adult myelodysplastic syndromes
        • Guidelines for the management of adult myelodysplastic syndromes
        • Guidelines for the Management of sickle cell disease in pregnancy
        • The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelod-ysplastic neoplasms, and related disorders
        • GPP Management of cardiovascular complications of bruton tyrosine kinase inhibitors
        • Clinical and laboratory diagnosis of heritable platelet disorders in adults and children
        • Cytomegalovirus serological testing in potential allogeneic haematopoietic stem cell transplant recipients
        • Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias
        • The management of Castleman disease
        • GPP Richter transformation of chronic lymphocytic leukaemia
        • Good Practice Paper for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children
        • Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma)
        • Guidelines on the diagnosis and management of Waldenström macroglobulinaemia
        • Guideline for the first-line management of Classical Hodgkin Lymphoma
        • Guidelines for the laboratory diagnosis of malaria
        • The Use of Next-generation Sequencing in the Diagnosis of Rare Inherited Anaemias: A Joint BSH/EHA Good Practice Paper
        • Guidelines for thrombophilia testing
        • Haematological management of major haemorrhage
        • Haematological evaluation of bruising and bleeding in children undergoing child protection investigation for possible physical maltreatment
        • Management of older patients with frailty and acute myeloid leukaemia: A British Society for Haematology good practice paper
        • Recommendations for laboratory testing of UK patients with acute myeloid leukaemia: A British Society for Haematology good practice paper
        • Management of secondary central nervous system lymphoma: A British Society for Haematology Good Practice Paper
        • Managing Bleeding Risk during Procedures in Interventional Radiology: Joint BSIRH and BSH Guidance
        • Guidelines for screening and management of late and long-term consequences of myeloma and its treatment
        • Guideline for anticoagulant management of pregnant individuals with mechanical heart valves
        • Significant haemoglobinopathies: A guideline for screening and diagnosis
        • Guideline on the investigation and management of acute transfusion reactions
        • Investigation and management of monoclonal gammopathy of undermined significance
        • Diagnosis and management of mantle cell lymphoma
        • Diagnosis and evaluation of prognosis of myelofibrosis
        • Diagnosis and management of marginal zone lymphomas
        • The management of myelofibrosis: A British Society for Haematology Guideline
        • Diagnosis and management of heparin-induced thrombocytopenia: Third edition
        • The management of newly diagnosed large B-cell lymphoma
        • Guidelines for the diagnosis and management of adult aplastic anaemia
        • Guidelines for the specification, implementation and management of IT systems in hospital transfusion laboratories
        • Diagnosis and management of smouldering myeloma
        • The assessment and management of bleeding risk prior to invasive procedures
        • Guideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the UKHCDO and the BSH
        • Prevention and treatment of infection in patients with an absent or hypofunctional spleen
        • Guideline on the use of predeposit autologous donation
        • Guideline for the Management of Conception and Pregnancy in Thalassaemia Syndromes
        • Cancer-associated venous thrombosis in adults (second edition)
        • Identification and management of preoperative anaemia in adults: A British Society for Haematology Guideline update
        • Diagnosis and initial treatment of transplant-eligible high-risk myeloma patients
        • Prevention and management of indwelling catheter-related thrombosis in sickle cell disease and thalassaemia
        • Guidelines on the investigation and management of antiphospholipid syndrome
        • Central nervous system prophylaxis in large B-cell lymphoma
        • Measurement of heparin, direct oral anti-coagulants and other non-coumarin anti-coagulants and their effects on haemostasis assays
        • Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma
        • Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma
        • Diagnosis and management of monoclonal gammopathy of renal significance
        • BSH position paper on the ESICM Guideline: ‘Transfusion strategies in non-bleeding critically ill adults’
        • Guideline for the investigation and management of red cell antibodies in pregnancy
        • Management of relapsed or refractory large B-cell lymphoma
        • Apheresis procedures for the treatment of patients and for the collection of cellular therapy products
        • Updated guidelines for the diagnosis and management of tumour lysis syndrome in adults and children
        • Clinical management of bispecific antibody therapy for lymphoma
        • Reporting haemostasis assays in IU/dL—A recommendation for harmonisation (BSH H&T Task Force / UK NEQAS / UK HCDO)
        • 2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia
        • Management of relapsed multiple myeloma: A BSH and UK Myeloma Society guideline
        • Laboratory investigation and clinical management of acquired coagulation factor inhibitors: A joint BSH & UKHCDO Guideline
        • Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations Guideline
        • Management of hepatitis B & C infection and subsequent liver disease surveillance in people with congenital bleeding disorders: BSH & BVHG joint Guideline
        • Use of andexanet alfa: A British Society for Haematology position statement
      • About our Guidelines
      • Proposing and writing a new BSH Guideline
      • For Guidelines writers and Taskforce Members
      • Archived Guidelines
      • ASM Guidelines Videos
    • Membership
      • Membership Signup
      • Meet our members
      • Your career and wellbeing
      • British Journal of Haematology
      • BSH-EHA Joint Membership
      • Membership FAQs
      • Event Proposal
    • Advocacy
      • The Haematology Workforce
    • Processing Notice
      • Cookies
    • Privacy Policy
    • Sitemap
    • Profile
    • Sign Up
    • Login
    • Login Success
    • Website Registration Required
    • Register Success
    • Forgot Password
    • Reset Password
    • Membership wizard
    • Membership Payment Confirmation
    • Membership Payment Failed
    • Membership Signup Confirmation
    • Proposer Verification Confirmation
    • Member Submission Failed
    • Member Renewal
    • Subscription Renewal complete
    • Subscription Renewal Failed
    • BSH Member access only
    • Full member access only
    • Committee or SIG application submitted
    • SIG Member access only
    • PHTN Member access only
    • My BSH
    • Website Signup
    • Thank you for contacting us
    • Event Signup
    • Event Payment Confirmation
    • Event Payment Failed
    • Event Booking Failed
    • Event delegate access only
    • Video Access Payment Failed
    • Image submission
    • Grant submission confirmation
    • Guidelines Declaration of Interest Form submission confirmation
    • Sounding Board sign up
    • Sounding Board feedback submitted
    • BSH Guidelines podcast feedback submitted
    • error
    • Access not permitted
    • Access temporarily unavailable
© British Society for Haematology 2025
The British Society for Haematology is registered in England and Wales as a Company Limited by Guarantee, No 02645706 and as a Charity, No 1005735 Registered Office and correspondence address: 100 White Lion Street London N1 9PF. Phone: 020 7713 0990
  • Terms
  • Processing Notice
  • Sitemap